Differential prognostic factors in low‐ and high‐burden de novo metastatic hormone‐sensitive prostate cancer patientsMasaki Shiota, Ken‐ichi Tabata, Ryotaro Tomida et al.|Cancer Science|2020Cited by 48
Potential effectiveness of local radiotherapy for extending survival and reducing symptomatic local events in patients with de novo metastatic prostate cancerNaoki Terada, Takashi Mizowaki, Toshihiro Saito et al.|BJUI Compass|2020Cited by 19
Novel metastatic burden‐stratified risk model in de novo metastatic hormone‐sensitive prostate cancerMasaki Shiota, Naoki Terada, Hiroshi Kitamura et al.|Cancer Science|2021Cited by 15
5-Nitrouracil stabilizes the plasma concentration values of 5-FU in colorectal cancer patients receiving capecitabineYoichiro Yoshida, Suguru Hasegawa, Yasuhiro Hashimoto et al.|Scientific Reports|2020Cited by 4
1931 SINGLE POSITIVE BIOPSY AND PSA LEVEL <10NG/ML WITH PROSTATE CANCER PATIENTS CAN NOT PREDICT UNILATERAL LESION IN RADICAL PROSTATECTOMY SPECIMENS IN CONTEMPORARY JAPANESE POPULATIONTakuya Koie, Chikara Οhyama, Koji Mitsuzuka et al.|The Journal of Urology|2013Cited by 0